Pfizer Inc. PFE
NYSE · United States · Health Technology
$28.52-0.20 (-0.70%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
New and acquired products brought in $3.2 billion globally in the second quarter, as Pfizer steers resources toward growth areas.
AbbVie offers faster-growing drug sales and a rising payout, while Pfizer’s much higher yield comes with a tougher recovery to prove.
Pfizer’s 6% yield remains funded, yet weaker cash generation and heavy debt leave income investors with little room for error.